Physician profile
Hector Colon
NPI 1366544132
$327.80
in general payments reported to CMS, 2019-2025
11 companies · $19.63 in 2025
The $19.63 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2021: $30.89 · 2023: $39.67 · 2024: $103 · 2025: $19.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $162.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $65.97 | 2019-2024 | Wallach Cryosurgical Equipment, Summit Doppler |
| Janssen Pharmaceuticals, INC | $48.10 | 2019 | |
| Hologic Sales and Service, LLC | $42.18 | 2024-2025 | Novasure, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Roche Diagnostics Corporation | $35.80 | 2019 | |
| Astellas Pharma US INC | $31.78 | 2024 | Veozah |
| Therapeuticsmd, INC. | $27.08 | 2019 | |
| Abbott Laboratories | $19.98 | 2023 | Proclaim |
| Biogen, INC. | $16.88 | 2021 | |
| Minerva Surgical, INC | $15.36 | 2024 | |
| Meditrina | $13.57 | 2024 | |
| Allergan, INC. | $11.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hector Colon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.